Description
Selank is studied in the neuropeptide literature for its proposed effects on brain-derived neurotrophic factor (BDNF) expression and GABAergic signaling, without the receptor profile associated with benzodiazepine-class compounds. Researchers use it in comparative studies against other nootropic and anxiolytic-research peptides, including Semax, to map structure-activity relationships within the tuftsin-derived peptide family.
Research Applications
- BDNF expression pathway research
- GABAergic signaling modulation studies
- Comparative nootropic peptide research
- Tuftsin-derived peptide structure-activity studies
- Neuropeptide behavioral model research
Disclaimer For laboratory research use only. Not for human consumption, clinical use, veterinary use, diagnosis, or therapeutic application.





Reviews
There are no reviews yet.